XML 42 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions Business Combination (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended 0 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended 6 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Jun. 28, 2014
Mar. 29, 2014
Dec. 28, 2013
Mar. 30, 2013
Jun. 28, 2014
May 01, 2014
Jun. 29, 2013
Jun. 30, 2012
Jun. 28, 2014
Tysabri [Member]
Minimum [Member]
Jun. 28, 2014
Tysabri [Member]
Maximum [Member]
Jun. 28, 2014
Prialt [Member]
Minimum [Member]
Jun. 28, 2014
Prialt [Member]
Maximum [Member]
Feb. 28, 2014
Aspen Global [Member]
Mar. 29, 2014
Aspen Global [Member]
Jun. 28, 2014
Aspen Global [Member]
Feb. 28, 2014
Aspen Global [Member]
Feb. 28, 2014
Aspen Global [Member]
Trademarks and Trade Names [Member]
Feb. 28, 2014
Aspen Global [Member]
Customer Relationships [Member]
Feb. 28, 2014
Aspen Global [Member]
Noncompete Agreements [Member]
Feb. 28, 2014
Aspen Global [Member]
Distribution And License Agreements [Member]
Feb. 18, 2014
Fera (methazolomide) [Member]
Mar. 29, 2014
Fera (methazolomide) [Member]
Jun. 28, 2014
Fera (methazolomide) [Member]
Feb. 18, 2014
Fera (methazolomide) [Member]
Feb. 18, 2014
Fera (methazolomide) [Member]
Trademarks and Trade Names [Member]
Feb. 18, 2014
Fera (methazolomide) [Member]
Customer Relationships [Member]
Feb. 18, 2014
Fera (methazolomide) [Member]
Noncompete Agreements [Member]
Feb. 18, 2014
Fera (methazolomide) [Member]
Distribution And License Agreements [Member]
Dec. 18, 2013
Elan Corporation [Member]
Mar. 29, 2014
Elan Corporation [Member]
Jun. 28, 2014
Elan Corporation [Member]
Dec. 18, 2013
Elan Corporation [Member]
Dec. 18, 2013
Elan Corporation [Member]
Trademarks and Trade Names [Member]
Dec. 18, 2013
Elan Corporation [Member]
Customer Relationships [Member]
Dec. 18, 2013
Elan Corporation [Member]
Noncompete Agreements [Member]
Dec. 18, 2013
Elan Corporation [Member]
Distribution And License Agreements [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
Jun. 28, 2014
Velcera, Inc. [Domain]
Jun. 29, 2013
Velcera, Inc. [Domain]
Apr. 01, 2013
Velcera, Inc. [Domain]
Feb. 01, 2013
Velcera, Inc. [Domain]
Feb. 01, 2013
Velcera, Inc. [Domain]
Developed Technology Rights [Member]
Jun. 28, 2014
Velcera, Inc. [Domain]
Trademarks and Trade Names [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
Trademarks and Trade Names [Member]
Jun. 28, 2014
Velcera, Inc. [Domain]
Customer Relationships [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
Customer Relationships [Member]
Jun. 28, 2014
Velcera, Inc. [Domain]
Noncompete Agreements [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
Noncompete Agreements [Member]
Jun. 28, 2014
Velcera, Inc. [Domain]
Distribution And License Agreements [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
Distribution And License Agreements [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
In Process Research and Development [Member]
Feb. 01, 2013
Velcera, Inc. [Domain]
favorable supply agreement [Domain]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Dec. 29, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Jun. 29, 2013
Cobrek Pharmaceuticals, Inc. [Domain]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
May 29, 2008
Cobrek Pharmaceuticals, Inc. [Domain]
Jun. 28, 2014
Cobrek Pharmaceuticals, Inc. [Domain]
Developed Technology Rights [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Developed Technology Rights [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Trademarks and Trade Names [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Customer Relationships [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Noncompete Agreements [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
Distribution And License Agreements [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
In Process Research and Development [Member]
Dec. 28, 2012
Cobrek Pharmaceuticals, Inc. [Domain]
favorable supply agreement [Domain]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Jun. 29, 2013
Sergeant's Pet Care Products, Inc. [Domain]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Jun. 29, 2013
Sergeant's Pet Care Products, Inc. [Domain]
Developed Technology Rights [Member]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Developed Technology Rights [Member]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Trademarks and Trade Names [Member]
Jun. 28, 2014
Sergeant's Pet Care Products, Inc. [Domain]
Customer Relationships [Member]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Customer Relationships [Member]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Noncompete Agreements [Member]
Jun. 28, 2014
Sergeant's Pet Care Products, Inc. [Domain]
Noncompete Agreements [Member]
Minimum [Member]
Jun. 28, 2014
Sergeant's Pet Care Products, Inc. [Domain]
Noncompete Agreements [Member]
Maximum [Member]
Dec. 29, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Distribution And License Agreements [Member]
Jun. 29, 2013
Sergeant's Pet Care Products, Inc. [Domain]
Distribution And License Agreements [Member]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
Distribution And License Agreements [Member]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
In Process Research and Development [Member]
Jun. 29, 2013
Sergeant's Pet Care Products, Inc. [Domain]
favorable supply agreement [Domain]
Oct. 01, 2012
Sergeant's Pet Care Products, Inc. [Domain]
favorable supply agreement [Domain]
Dec. 28, 2013
Vedants Drug and Fine Chemicals Private Ltd [Member]
Jun. 27, 2009
Vedants Drug and Fine Chemicals Private Ltd [Member]
Aug. 06, 2009
Vedants Drug and Fine Chemicals Private Ltd [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Jun. 29, 2013
Fera Pharmaceuticals, LLC [Domain]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Jun. 28, 2014
Fera Pharmaceuticals, LLC [Domain]
Developed Technology Rights [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Developed Technology Rights [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Trademarks and Trade Names [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Customer Relationships [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Noncompete Agreements [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
Distribution And License Agreements [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
In Process Research and Development [Member]
Jun. 17, 2013
Fera Pharmaceuticals, LLC [Domain]
favorable supply agreement [Domain]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Jun. 29, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Mar. 30, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Jun. 29, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Jun. 28, 2014
Rosemont Pharmaceuticals Ltd. [Domain]
Developed Technology Rights [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Developed Technology Rights [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Trademarks and Trade Names [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Customer Relationships [Member]
Jun. 28, 2014
Rosemont Pharmaceuticals Ltd. [Domain]
Noncompete Agreements [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Noncompete Agreements [Member]
Jun. 28, 2014
Rosemont Pharmaceuticals Ltd. [Domain]
Distribution And License Agreements [Member]
Jun. 29, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Distribution And License Agreements [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
Distribution And License Agreements [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
In Process Research and Development [Member]
Feb. 11, 2013
Rosemont Pharmaceuticals Ltd. [Domain]
favorable supply agreement [Domain]
Business Acquisition [Line Items]                                                                                                                                                                                                                                
Business Acquisition, Percentage of Voting Interests Acquired                                                               29.00%               100.00%                                                                                     15.00%   85.00%                               100.00%                      
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests         $ 7.2                                                                                                                                                           $ 7.2 $ 11.5                                                        
Payment for Business Combination, Cash Payment                         53.7               17.3               9,451.9               175.1                               51.5                         285.0                                       88.4                     282.9                              
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage                                                                                                               81.50% 18.50%                                                                                                              
Payment for Business Combination, Cash Payment                                                                                                               42.0 12.6                                                                                                              
Loss on sales of investments       1.6 12.7   4.7 0                                                                                           3.0                                                                                                                    
Severance Costs                                                                                                           1.5                                                                                                                    
Contingent consideration 17.4       17.4   22.2                 0               0.8               0                 0                             0                       0                                       22.2                         0                      
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles                                             0.8               (300.0)                                                                                                                                                                  
Percent of royalty revenues generated by specific agreement         92.00% 12.00%     18.00% 25.00% 7.00% 17.50%                                                                                                                                                                                                        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                                                                                     25 years   20 years   3 years   10 years                 12 years                     10 years     20 years     1 year 3 years         7 years               15 years                         14 years       3 years   7 years        
Business Acquisition, Effective Date of Acquisition                             Feb. 28, 2014               Feb. 18, 2014               Dec. 18, 2013               Apr. 01, 2013                               Feb. 11, 2013                       Oct. 01, 2012                                       Jun. 17, 2013                         Dec. 28, 2012                        
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities                                                             28.8                                                                                                                                                                  
Business combination provisional adjustment, initial valuation incomplete, non-current liabilities                                                             8.8                                                                                                                                                                  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, net deferred taxes                                                             (67.7)                                                                                                                                                                  
Purchase Accounting Adjustments                                                             269.4                                                                                                                                                                  
Business combination purchase price adjustment                                                             (0.5)                                                                                                                                                                  
Business Combination, Consideration Transferred                           53.7               18.1               9,451.9                 175.1                               51.5                       285.0                                       110.6                         282.9                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets                               0               0               1,807.3                 18.9                             0                       0                                       0                         2.1                      
business combination, recognized identifiable assets acquired and liabilities assumed, investments                               0               0               100.0                                                                                                                                                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables                               0               0               44.2                 6.3                             0                       19.7                                       0                         10.6                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory                               2.7               0.3               0                 9.7                             0                       37.7                                       1.3                         9.6                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets                               0               0               27.1                                                                                                                                                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment                               0               0               9.2                 0.6                             0                       25.4                                       0                         13.1                      
Goodwill 3,474.1       3,474.1   1,089.2 777.8               4.6               0             2,346.0 2,346.0                 62.5                             15.3                       80.2                                       2.8                         147.0                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                               46.4 34.8 9.8 1.8 0       17.8 0 0 0 17.8       5,811.0 0 0 0 5,811.0         135.3 0   7.6   8.7   3.0   116.0 0 0       51.1     51.1 0 0 0 0 0 0     135.4   66.1 33.0   10.0 0         1.3 0   25.0           107.0   107.0 0 0 0 0 0 0         148.2   114.6 17.3 0   1.5     3.6 11.2 0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Noncurrent                                                                                 7.9                             3.6                       1.5                                       0                         0.2                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets                               0               0               93.4                 0.4                             0.3                       3.0                                       0                         0.8                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets                               53.7               18.1               10,238.2                 241.6                             70.3                       302.9                                       111.1                         331.6                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable                               0               0               2.0                 6.5                             0                       13.7                                       0                         2.6                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities                               0               0               118.6                 4.8                             0                       4.2                                       0.5                         7.6                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent                               0               0               634.5                 48.2                             18.8                       0                                       0                         36.0                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities                               0               0               31.2                 7.0                             0                       0                                       0                         2.5                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities                               0               0               786.3                 66.5                             18.8                       17.9                                       0.5                         48.7                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net                               53.7               18.1               9,451.9                 175.1                             51.5                       285.0                                       110.6                         282.9                      
Restructuring charges 10.5 19.5 14.9   47.0   2.9 8.8                                             41.2             1.4 2.9                                                                                                                                                  
Business Acquisition, Transaction Costs                                                                             2.7                                                                                                                                                  
Inventory step-up charges                                                                                                                                                         7.7                                         1.2 1.9                   3.2      
Fixed Assets Fair Value Adjustment                                                                                                                                                           6.1                                                             4.9      
Business Combination, Purchase Price Allocation Adjustment, Intangible Assets                                                                           3.0                                                                                                                                                    
Business Combination, Purchase Price Allocation Adjustment, Deferred Tax Assets                                                                                                             3.6                                                                                                                  
Business Combination, Purchase Price Allocation Adjustment, Other Intangible Assets                                                                                                                                     12.0                                                                                          
Business Combination, Acquisition Related Costs                                                             $ 284.9